Product image of Linola Akut (Hydrocortisone) supplied by GNH India

Linola Akut

Active Ingredient:
Hydrocortisone
Origin:
EU

Linola Akut (Hydrocortisone)

Hydrocortisone, the active ingredient in Linola Akut, is a corticosteroid presented as a topical formulation for skin application. It helps reduce inflammation, redness and itching associated with various dermatological conditions in adults and children.
GNH India supplies Linola Akut as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Dr. August Wolff Gmbh & Co. Kg Arzneimittel

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Hydrocortisone is a topical corticosteroid used to reduce inflammation and itching in various skin conditions.
  • Eczema: alleviates redness, swelling and pruritus in mild to moderate atopic dermatitis.
  • Dermatitis: decreases inflammation and discomfort in contact and allergic dermatitis.
  • Insect bites: relieves local swelling, redness and itching caused by insect stings.
  • Sunburn: soothes erythema and pain associated with mild solar skin injury.

How It Works

  • Hydrocortisone binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. This action suppresses the synthesis of pro‑inflammatory cytokines, prostaglandins and leukotrienes, while promoting anti‑inflammatory proteins, resulting in reduced vascular permeability, edema and immune cell activation at the site of application.

Side Effects

Topical hydrocortisone may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Skin irritation or burning sensation at the application site.
  • Dryness or peeling of the treated skin.
  • Redness or mild erythema.
  • Pruritus or itching.
  • Folliculitis or acneiform eruptions.
  • Minor stinging or tingling.

Serious or Rare Side Effects

  • Skin atrophy or thinning with prolonged use.
  • Telangiectasia (visible small blood vessels).
  • Contact allergic dermatitis.
  • Systemic absorption leading to adrenal suppression.
  • Secondary infection of the skin.
  • Hypertrichosis (excessive hair growth).

Precautions & Warnings

When using Linola Akut, consider the following safety measures.

  • Avoid prolonged continuous use: limit application to the shortest effective period.
  • Do not apply to infected, ulcerated or broken skin unless directed by a clinician.
  • Use the smallest amount necessary to cover the affected area.
  • Avoid occlusive dressings unless specifically prescribed.
  • Pregnancy and lactation: consult a healthcare professional before use.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Topical hydrocortisone can interact with other agents, affecting absorption or systemic effects.

Major Interactions (Avoid)

  • Systemic corticosteroids: may increase risk of systemic glucocorticoid side effects.
  • Immunosuppressants (e.g., cyclosporine): heightened risk of infection.

Moderate Interactions (Monitor Closely)

  • Antifungal agents (e.g., ketoconazole): may increase percutaneous absorption.
  • NSAID topical preparations: potential for increased local irritation.
  • Photosensitizing drugs (e.g., tetracyclines): may enhance photosensitivity reactions.
  • Occlusive bandages combined with other topical steroids: risk of excessive absorption.

Frequently Asked Questions

Linola Akut contains hydrocortisone, a topical corticosteroid that is used to relieve inflammation, redness and itching associated with mild skin conditions such as eczema, dermatitis, insect bites and minor sunburn. It is applied directly to the affected skin area to provide symptomatic relief.

Hydrocortisone binds to glucocorticoid receptors inside skin cells, altering gene transcription. This reduces the production of inflammatory mediators like cytokines and prostaglandins, leading to decreased swelling, redness and immune cell activity at the site of application.

The appropriate amount and frequency of Linola Akut are determined by the prescribing healthcare professional based on the severity of the skin condition, the patient’s age and the treatment area. Patients should follow the prescriber’s instructions and not exceed the recommended usage.

Safety of topical hydrocortisone during pregnancy or lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Linola Akut.

To place an order, submit an enquiry on the Linola Akut product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Linola Akut contains hydrocortisone, a low‑potency corticosteroid, making it suitable for mild to moderate skin irritation. Higher‑potency steroids such as betamethasone or clobetasol provide stronger anti‑inflammatory effects but carry greater risk of side effects. Choice of product depends on the condition’s severity and physician assessment.

Linola Akut should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and avoid freezing. Do not use the product if the packaging is damaged or the cream appears discolored.

Apply a thin layer of Linola Akut to the clean, dry skin area affected by the condition. Gently rub it in until fully absorbed. Follow the prescriber’s directions regarding frequency, typically 1–3 times daily, and avoid covering the area with airtight dressings unless instructed.

Serious risks include skin atrophy, telangiectasia, secondary infections, and systemic effects such as adrenal suppression when used over large areas or for prolonged periods. Patients should report any unusual thinning of the skin, persistent redness, or signs of systemic hormonal effects to their healthcare provider.

Linola Akut should be avoided in individuals with known hypersensitivity to hydrocortisone or any excipients in the formulation, in patients with viral skin infections (e.g., herpes simplex) unless directed, and in those where systemic corticosteroid therapy is contraindicated. Consultation with a clinician is essential before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Hydrocortisone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT